KCT is looking for two Senior Scientists for two different projects:
Project 1. In this project, the successful candidate will be developing T and NK based cell therapy products for ovarian and brain cancers. Lentivirus technology and CRIPR-Cas will be utilized in genetic engineering of the cells for cancer targeting and improved performance in solid cancer treatments. The candidate will closely work together with KCT team developing clinical grade cell therapy product processes. KCT research team has already established in vitro and in vivo methods to further characterize and functionally test the developed products.
Project 2. In this project, the successful candidate will participate in establishing 3-D cultures and characterization of ovarian and brain tumors. Cell culture, immunological and molecular methods are extensively utilized. The candidate will also participate in single-cell sequencing and proteomics characterizations involving collaborative laboratories specialist in these techniques. The candidate will work together with KCT research team with extensive knowledge in cell biology, immunology and bioinformatics.
The successful candidates will be responsible for designing, implementing and overseeing the project. These duties will involve practical laboratory technologies, and therefore strong wet lab background is essential. This person will work closely together with internal project teams and external collaborators and therefore have excellent communication skills in English.
Skills and experience in the following areas is highly desirable:
The positions are initially for three years. International candidates are strongly encouraged to apply. KCT’s HR team are available to help with issues related to relocation.
Further information (firstname.lastname@example.org):
Tuija Kekarainen, Cell Therapy Unit Director
Anssi Kailaanmäki, Head of Immunology
Katja Puttonen, Head of Process Development
Johanna Pirinen, HR Director
Kuopio Center for Gene and Cell Therapy (KCT) is a modern research institute located in Kuopio, Finland. Our mission is to conduct high-level research on basic and translational fields of gene- and cell therapy. The centre’s niche is in the interface between academic, basic research and the commercial biotechnology industry. KCT provides an exciting environment for applied research and discovery, developing therapeutic products through Phase I clinical trials and utilizing some of the most advanced analytical and mechanistic proof-of-principle approaches in the sector. Opportunities for two highly motivated Senior Scientists have now opened at the KCT Immunotherapy Program to work in projects that revolve around cancer and immune cell genetic engineering. Both projects are already active in KCT and involve clinicians, academic teams and international collaborators.